A Tabula Rasa for pharmacy consulting

The FDA set a Prescription Drug User Fee Act (PDUFA) date of April 28, 2026.

Dae Lee, PharmD, Esq, CPBS and Lucas Morgan, Esq, discuss PBM and board of pharmacy enforcement actions, trends in PBM audits, and more.

This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.

As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.

Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.

SF 383 prohibits PBMs from limiting patient choice of pharmacy, unfairly excluding pharmacies from networks, and forces them to reimburse pharmacies no less than what they pay affiliated pharmacies for the same drug.